ERBB3 and neoplasm: Interestingly, using the RTJ.2 mAb the cellular location of HER-3 was mostly nuclear and of these, at cut-off value of above 5% of tumour cells with positive immunostaining was detected in 39/60 (65%) of the cases examined (Table 2, Figure 1).